Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial - Torres, A; Zhong, N; Pachl, J (Lancet Infect Dis, 2018)
, et al.